Sökning: WFRF:(Fu Y. F.)
> (2020-2024) >
Intra-aortic balloo...
Intra-aortic balloon pump on in-hospital outcomes of cardiogenic shock: findings from a nationwide registry, China
-
Chu, S. Y. (författare)
-
Sun, P. F. (författare)
-
Zhang, Y. (författare)
-
visa fler...
-
Li, J. P. (författare)
-
Liu, L. (författare)
-
Shi, Y. (författare)
-
Wang, H. B. (författare)
-
Chen, H. (författare)
-
- Fu, Michael, 1963 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine
-
Huo, Y. (författare)
-
visa färre...
-
(creator_code:org_t)
- 2021-06-21
- 2021
- Engelska.
-
Ingår i: ESC Heart Failure. - : Wiley. - 2055-5822. ; 8:4, s. 3286-3294
- Relaterad länk:
-
https://onlinelibrar...
-
visa fler...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Aims The real-world usage of intra-aortic balloon pump (IABP) in various cardiogenic shocks (CS) and the association with outcomes are lacking. We aimed to investigate IABP adoption in CS in a nationwide registry in China. Methods and results We retrospectively retrieved data of 30 106 CS patients (age 67.1 +/- 14.6 years, 37.6% female patients) in the Hospital Quality Monitoring System registry from 2013 to 2016. Ischaemic heart disease was the leading cause of CS (73.9%). Hypertension, cardiomyopathy, myocarditis, valvular, and congenital heart disease were seen in 36.0%, 7.5%, 2.6%, 7.3%, and 2.4% of the population. IABP was employed in 2320 (7.7%) subjects. The association between IABP usage and primary outcome of in-hospital mortality and secondary outcomes of expenses and lengths of stay were investigated. The patients with IABP support had similar in-hospital mortality to those without IABP (39.6% vs. 38.3%, P = 0.226), but longer hospital-stay [8.0 (2.0-16.0) vs. 6.0 (2.0-13.0) days, P < 0.001] and higher expenses [7.1(4.4-11.1) vs. 2.3 (0.8-5.5) 10 000RMB, P < 0.001]. IABP support was not associated with reduced mortality in the overall CS population in multivariate regression analysis [odds ratio (OR) 1.05, 95% confidence interval (CI) 0.95-1.17], except for subgroups with myocarditis (OR 0.61, 95% Cl 0.39-0.95, P for interaction = 0.010) and those who did not receive the early percutaneous coronary intervention (PCI) (OR 0.86, 95% CI 0.75-0.97, P for interaction < 0.001). Similar results were further confirmed in the propensityscore-matched population. Conclusions In this nationwide registry of CS patients, IABP was not noted with improved survival but increased healthcare consumption. However, IABP appears protective in those with myocarditis or who failed to receive early PCI.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- Intra-aortic balloon pump
- Cardiogenic shock
- Mortality
- acute myocardial-infarction
- heart-failure
- trends
- revascularization
- counterpulsation
- management
- support
- guidelines
- stage
- Cardiovascular System & Cardiology
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Chu, S. Y.
-
Sun, P. F.
-
Zhang, Y.
-
Li, J. P.
-
Liu, L.
-
Shi, Y.
-
visa fler...
-
Wang, H. B.
-
Chen, H.
-
Fu, Michael, 196 ...
-
Huo, Y.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
ESC Heart Failur ...
- Av lärosätet
-
Göteborgs universitet